Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-20

Clinical Trial Update: Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19 [Phase 3]

View source ↗

Summary

Phase 3 trial exploring BCG vaccine for immune-prophylaxis in Egyptian healthcare workers during COVID-19 pandemic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: Ain Shams University | Conditions: Coronavirus Disease (COVID-19) | Phase 3 | Status: UNKNOWN